Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Novo Nordisk: The Wegovy Pill Surprise and the CagriSema Setback Novo Nordisk's Q1 2026 results contained one clear win and one significant loss
Despite these numbers, GLP-1 drugs account for relatively small shares of total Medicaid spending and prescriptions, the report noted -- about 0.5% of all Medicaid prescriptions and 3.7% of gross Medicaid spending
Oversight transforms uncertainty into confidence
Step down one dose level at a time rather than stopping abruptly
Moreover, these hormones contribute to beta cell proliferation and longevity, which is particularly relevant in type 2 diabetes where beta cell function is compromised
Potential New Respiratory Treatment Researchers propose GLP-1 agonists should be further studied and considered as a therapeutic option for respiratory diseases in people with obesity
